NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.230
+0.010 (0.82%)
Dec 5, 2025, 4:00 PM EST - Market closed
NanoViricides Market Cap
NanoViricides has a market cap or net worth of $22.14 million as of December 5, 2025. Its market cap has increased by 19.66% in one year.
Market Cap
22.14M
Enterprise Value
21.01M
1-Year Change
19.66%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since September 25, 2013, NanoViricides's market cap has decreased from $293.90M to $22.14M, a decrease of -92.47%. That is a compound annual growth rate of -19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 22.00M | 7.32% |
| Dec 31, 2024 | 20.50M | 70.83% |
| Dec 29, 2023 | 12.00M | -6.98% |
| Dec 30, 2022 | 12.90M | -69.93% |
| Dec 31, 2021 | 42.90M | 40.20% |
| Dec 31, 2020 | 30.60M | 215.46% |
| Dec 31, 2019 | 9.70M | -30.22% |
| Dec 31, 2018 | 13.90M | -75.04% |
| Dec 29, 2017 | 55.70M | -10.59% |
| Dec 30, 2016 | 62.30M | -8.38% |
| Dec 31, 2015 | 68.00M | -56.21% |
| Dec 31, 2014 | 155.30M | -35.32% |
| Dec 31, 2013 | 240.10M | -18.31% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |